GADD45G and central nervous system cancer: We have addressed this limitation in the manuscript and plan to expand our scRNA-seq analyses to include more publicly available datasets with spatial information and treatment-specific contexts, as well as generate our own high-resolution scRNA-seq data from freshly collected clinical glioma samples, thereby enabling more controlled analyses of GADD45G expression across distinct cellular and microenvironmental contexts.